Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "hydrochloride" wg kryterium: Temat


Wyświetlanie 1-2 z 2
Tytuł:
DETERMINATION OF FLUOXETINE HYDROCHLORIDE VIA ION PAIR COMPLEXATION WITH ALIZARIN RED S
Autorzy:
Clementina, Constantinescu I.
Alexandra, Neagu F.
Valentina, Uivarosi
Powiązania:
https://bibliotekanauki.pl/articles/895425.pdf
Data publikacji:
2018-12-31
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
spectrophotometry
Alizarin Red S
fluoxetine hydrochloride
ion pair
fluorimetry
Opis:
Two UV-Vis spectrophotometric methods and one fluorimetric method have been developed for the quantitative determination of fluoxetine hydrochloride in bulk and pharmaceutical formulations. These methods are based on the ion pair complex formation between alizarin red S and fluoxetine hydrochloride. In the first method (method A), the yellow-coloured complex obtained in acidic medium was extracted with chloroform, and the absorbance of chloroformic solution was measured at 425 nm. Beer’s law limits (9.5 – 48 µg/mL), the molar absorptivity (5256 L · mol-1· cm-1), and the complex composition (1:1) were determined. In the second method (method B), the yellow complex fluoxetine – alizarin red S extracted in chloroform was broken in alkaline medium, and the absorbance of the resulting violet-coloured free dye was measured at 524 nm. A linear relationship was observed in the range 9.0 – 54 µg/mL. In the third method (method C) the fluorescence intensity of the fluoxetine – alizarin red S complex, obtained in the same manner as for method A, was measured at 594 nm after excitation at 425 nm. The fluorescence intensity was proportional to the drug concentration in the linear range of 2.7-10.2 µg/mL. The limits of detection and quantification have also been calculated. Furthermore, the proposed methods have been successfully applied for the assay of the drug in pharmaceutical dosage forms.
Źródło:
Acta Poloniae Pharmaceutica - Drug Research; 2018, 75, 6; 1293-1303
0001-6837
2353-5288
Pojawia się w:
Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The effect of co-processed dry binder with microcrystalline cellulose on release of verapamil hydrochloride from hydrophilic matrix tablets
Autorzy:
Komersová, Alena
Lochař, Václav
Myslíková, Kateřina
Mužíková, Jitka
Bartoš, Martin
Powiązania:
https://bibliotekanauki.pl/articles/895631.pdf
Data publikacji:
2018-10-31
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
matrix tablets
Dissolution kinetics
Verapamil hydrochloride
hypromellose
Comprecel® 102
MicroceLac®100
Opis:
The aim of this study was to evaluate the use of co-processed dry binder MicroceLac®100 (lactose and microcrystalline cellulose in ratio 3:1) and Comprecel® 102 (pure microcrystalline cellulose) in formulations for the extended release of verapamil hydrochloride. Hydrophilic matrix tablets containing verapamil hydrochloride, hypromellose and dry binder were prepared by the direct compression method. Hypromelloses MethocelTM K4M Premium CR or MethocelTM K100M Premium CR were used as controlled release agents. Using scanning electron microscopy regular distribution of the active substance in the prepared tablets was confirmed. Release of verapamil hydrochloride from the prepared formulations was studied by the dissolution test method. The dissolution profiles were fitted to the first-order kinetic model, Higuchi diffusion model, Korsmeyer-Peppas and Weibull model and kinetic parameters as the first order release rate constant (k1), release exponent (n) from Korsmeyer-Peppas model, Higuchi constant (KH) and parameters of Weibull model (b, λ) were determined. Based on results of non-linear regression analysis, the higher release rate constants were found for formulations containing co-processed dry binder MicroceLac®100 in comparison with formulations containing pure microcrystalline cellulose (Comprecel® 102). In addition, tablets swelling, erosion and disintegration during the dissolution test were monitored photographically.
Źródło:
Acta Poloniae Pharmaceutica - Drug Research; 2018, 75, 5; 1223-1231
0001-6837
2353-5288
Pojawia się w:
Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies